07:00 , Jun 16, 2014 |  BC Week In Review  |  Clinical News

Euroimmun anti-PLA2R IFA regulatory update

FDA granted clearance to Euroimmun's Euroimmun anti-PLA2R IFA blood test as an aid to diagnose primary membranous glomerulonephritis, a type of kidney disease. FDA said some cases of membranous glomerulonephritis are associated with secondary conditions...
07:00 , Jul 23, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Renal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Glomerulonephritis Anti-phospholipase A2...